Hepatitis

;

Biden budget boosts domestic HIV funding & proposes PrEP & Hepatitis C programs

Mar 9, 2023

“President Biden’s budget is yet another demonstration of his leadership in ending HIV. He recognizes the historic role the federal government must play, and the investments needed to end infectious diseases, such as HIV and hepatitis C,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “Now, it is essential that Congress works together to ensure it maintains the federal government’s commitment to ending HIV and at the same time, invests the necessary resources to end hepatitis. We also must guard against any erosion in funding of these programs, as some have proposed,” continued Schmid.

read more

Congress lifts Ending HIV Epidemic initiative funding by $100 million

Dec 20, 2022

Congressional appropriators have released the final FY2023 appropriations bill and have increased funding for the Ending the HIV Epidemic in the U.S. initiative by $100 million for a total of $613 million, according to the Appropriations Committee.  While far short of the $330 million increase proposed in President Biden’s budget, it does provide increases to ramp up domestic HIV testing, prevention, and treatment programs in order to end HIV.

read more

CDC data shows only one-third of people diagnosed with hepatitis C access treatment

Aug 9, 2022

Today, the Centers for Disease Control and Prevention (CDC) released disturbing data that shows that only one-third of people diagnosed with hepatitis C who have healthcare coverage are being treated with curative medications within one year of diagnosis. “Despite having health coverage and cost-effective drugs that can cure hepatitis C in as little as 8-12 weeks, our healthcare system is failing to provide the treatment people with hepatitis C need and is required to end this potentially deadly infectious disease,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.

read more

Senate Appropriations leadership proposes significant increases for domestic HIV programs

Jul 28, 2022

The leadership of the United States Senate Appropriations Committee is proposing to significantly increase funding to continue to ramp up efforts to end HIV in the United States.  The Senate bills include increased funding for the Ending the HIV Epidemic in the U.S. initiative by at least $240 million for domestic HIV testing, prevention, treatment, and research programs. While it is not as much as proposed in President Biden’s budget, in some instances it is more than what was proposed by the House.

read more

Congressional funding slows for ending HIV initiative: Hepatitis programs left with a minimal increase

Mar 9, 2022

In the omnibus appropriations bill released today, Congress has significantly slowed the increase of funding for the Ending the HIV Epidemic in the U.S. initiative and put in jeopardy efforts to end HIV by 2030. Instead of supporting an increase of $245 million, as was proposed in President Biden’s budget and passed by the House and proposed by Senate Democratic leaders, the final bill allocates an increase of only $70 million for HIV testing, prevention, treatment, and research programs for those jurisdictions most impacted by HIV.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest